ESR1 and breast carcinoma: AA was tested on the estrogen receptor (+) MCF7 as well as on the estrogen receptor (-) MDA-MB-231 breast cancer cell lines, inhibiting both cell lines but acting stronger against MDA-MB-231 cells [41].